Quantbot Technologies’s Vor Biopharma VOR Stock Holding History

Quantbot Technologies’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-307	Closed	-$5.48K	–	2283
2026 Q1	$5.48K	Buy	+307	New	+$4.33K	﹤0.01%	1574

Other funds holding VOR

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Quantbot Technologies's VOR Position: Q2 2026 in Review

Quantbot Technologies sold out of Vor Biopharma (VOR) in Q2 2026, closing a stake of 307 shares — an estimated $5.48K sold.

Quantbot Technologies first reported a position in VOR in Q1 2026 and held it in 1 quarter. The position peaked at $5.48K in Q1 2026. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

Quantbot Technologies reported no remaining Vor Biopharma position as of Q2 2026 after selling out during the quarter.
Quantbot Technologies sold 307 Vor Biopharma shares in Q2 2026, an estimated $5.48K.
Quantbot Technologies first reported a position in Vor Biopharma in Q1 2026 and held it in 1 quarter.
Quantbot Technologies's Vor Biopharma position peaked at $5.48K in Q1 2026.
102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.